They pay their premiums, but they pay nothing else out of pocket
Oncotarget (2017) 8(63):106693706
Stabile LP, He G, Lui VW, Thomas S, Henry C, Gubish CT, et al
Individuals with certain MC4R genotypes may experience a weaker subjective appetite reduction from the same GLP-1 dose not because the medication isn't working pharmacologically, but because the downstream receptor response is genetically attenuated
The result is accelerated colonic transit in some patients, leading to looser stools and diarrhea
This article asserts that although some compounding pharmacies are legitimate and regulated by state boards, other compounded semaglutide suppliers are not regulated, including weight or wellness clinics and medical spas